Biomarkers in DILI: One More Step Forward

Despite being relatively rare, drug-induced liver injury (DILI) is a serious condition, both for the individual patient due to the risk of acute liver failure, and for the drug development industry and regulatory agencies due to associations with drug development attritions, black box warnings, and...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Pharmacol
Autors principals: Robles-Díaz, Mercedes, Medina-Caliz, Inmaculada, Stephens, Camilla, Andrade, Raúl J., Lucena, M. Isabel
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2016
Matèries:
Pharmacology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4992729/
https://ncbi.nlm.nih.gov/pubmed/27597831
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2016.00267
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars